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Introduction
Pathogen recognition receptors (PRRs) trigger innate immune re­
sponses after sensing microbial components such as lipopoly­
saccharide (LPS), lipoprotein, flagellin, and nucleic acids and are 
necessary for the protection of a host suffering from microbial in­
fection (Beutler, 2009; Kawai and Akira, 2009). After detecting 
microbial components, PRRs drive the coordinated activation of 
transcription factors, leading to the expression of inflammatory 
cytokines, chemokines, type I interferons (IFNs), and antimicro­
bial genes. Although innate immunity is essential for host de­
fense, aberrant activation of innate immune responses results in 
the development of inflammatory diseases; e.g., autoimmune dis­
ease and septic shock. Thus, the signaling pathways of the innate 
immune system are tightly regulated to avoid either deficient or 
excessive responses.
Protein degradation is critically involved in the control of 
innate immune responses (Beutler, 2009; Kawai and Akira, 2009). 
Although the regulation of immune responses by the ubiquitin–
proteasome (a selective protein degradation system) has long 
been studied (Liu et al., 2005; Bhoj and Chen, 2009), recent re­
search has shown the involvement of another clearance system, 
autophagy, in the innate immune response. Autophagy is a bulk 
degradation system that delivers cytoplasmic constituents into   
lysosomes (Fig. 1; He and Klionsky, 2009; Nakatogawa et al., 
2009). This process enables the reuse of intracellular constituents 
and supplies an amino acid pool during periods of starvation.   
Indeed, mice deficient in Atg3, Atg5, or Atg7 die within 1 d of 
delivery, indicating that autophagy is essential for survival during 
neonatal starvation (Kuma et al., 2004; Komatsu et al., 2005; Sou 
et al., 2008). Autophagy is also involved in the clearance of old/
damaged organelles, long­lived proteins, insoluble protein aggre­
gates, and lipid droplets, thus regulating cellular homeostasis, cell 
death/survival, and lipid metabolism (Yoshimori and Noda, 2008; 
Mizushima, 2009; Czaja, 2010). Several essential components of 
the autophagic machinery have been identified by yeast genetic 
screening, the so­called autophagy­related proteins (Atgs; He and 
Klionsky, 2009; Nakatogawa et al., 2009). Recent studies have 
identified mammalian counterparts of yeast Atgs, such as ULK1 
(Atg1), Atg3–5, beclin (Atg6), Atg7, LC3 (Atg8), Atg9a, Atg10, 
Atg12, Atg13L, Atg14L, Atg16L1, FIP200 (Atg17), and WIPI­1 
(Atg18), indicating that Atgs are phylogenetically highly con­
served between yeast and mammals (Mizushima et al., 1998a,b; 
2003; Liang et al., 1999; Kabeya et al., 2000; Tanida et al., 2001, 
2002; Mariño et al., 2003; Proikas­Cezanne et al., 2004; Yamada 
et al., 2005; Young et al., 2006; Hara et al., 2008; Itakura et al., 
2008; Sun et al., 2008; Chan et al., 2009; Chang et al., 2009; 
Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009; 
Matsunaga et al., 2009; Zhong et al., 2009). The coordinated   
action of Atgs mediates the membrane trafficking required for 
autophagosome formation (Fig. 1).
Autophagy plays a critical role in host defense responses by 
promoting the elimination of pathogens and the induction of ac­
quired immunity (Deretic, 2005; Deretic and Levine, 2009; Virgin 
and Levine, 2009). The Rab7­dependent formation of bacteria­
containing autophagosomes is critical for the killing of invading 
bacteria, such as Streptococcus pyogenes and Coxiella burnetii, 
Pattern recognition receptors detect microbial components 
and induce innate immune responses, the first line of host 
defense against infectious agents. However, aberrant acti-
vation of immune responses often causes massive inflamma-
tion, leading to the development of autoimmune diseases. 
Therefore,  both  activation  and  inactivation  of  innate   
immune responses must be strictly controlled. Recent studies 
have shown that the cellular machinery associated with 
protein degradation, such as autophagy, is important for 
the regulation of innate immunity. These studies reveal that 
autophagy-related proteins are involved in the innate   
immune response and may contribute to the development 
of inflammatory disorders.
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Autophagy and inflammation
Recent genome­wide association studies have identified Atg16L1 
as a candidate gene responsible for susceptibility to the inflam­
matory bowel disease, Crohn’s disease (Hampe et al., 2007; 
Rioux et al., 2007). Atg16L1 forms an 800­kD protein com­
plex with Atg12­Atg5 conjugates, and the self­multimerization 
of Atg16L1 via its coiled­coil domain is required for the recruit­
ment of this conjugate into an isolation membrane (a source 
membrane of autophagosomes; Fig. 1; Mizushima et al., 2003; 
Fujita et al., 2008). The Atg12­Atg5–Atg16L1 complex recruits 
an Atg3­LC3 intermediate to the isolation membrane, and in doing 
so, defines the site at which LC3 is conjugated to phosphatidyl­
ethanolamine (Fujita et al., 2008). Consistently, cells lacking 
Atg16L1 are deficient in the conjugation of LC3 to phosphati­
dylethanolamine, an essential process for the elongation of   
autophagosomes (Saitoh et al., 2008). Mice lacking Atg16L1 
cannot survive neonatal starvation periods. This phenotype is 
similar to that observed in other Atg­deficient mice (Kuma et al., 
2004; Komatsu et al., 2005). Thus, Atg16L1 is an essential com­
ponent of autophagy under both nutrient­rich and nutrient­
starved conditions.
Using Atg16L1­deficient mice, we have shown that the 
loss  of Atg16L1  enhances  endotoxin­induced  inflammatory 
immune responses (Fig. 2 A; Saitoh et al., 2008). Commensal 
bacteria are thought to be one of the major causative agents of 
bowel  disease. When  intestinal  epithelial  cells  are  damaged, 
commensal bacteria are able to pass through the epithelial layer 
and stimulate PRRs, leading to the induction of intestinal inflam­
mation. Toll­like receptors (TLRs), one family of PRRs, detect 
microbial components and induce the production of inflamma­
tory cytokines such as TNF­, IL­1, IL­6, IL­12, and IL­18 by 
macrophages/dendritic cells (DCs), resulting in the infiltration 
of activated lymphocytes into the intestine (Beutler, 2009; Kawai 
and Akira, 2009). Macrophages lacking Atg16L1 produce high 
amounts of IL­1 and IL­18 in response to LPS, a ligand for 
TLR4. Macrophages from Atg7­deficient mice also show en­
hanced production of IL­1, indicating the importance of Atg in 
in nonphagocytic cells (Berón et al., 2002; Nakagawa et al., 2004; 
Romano et al., 2007; Yamaguchi et al., 2009). Bacteria, such as 
Shigella flexneri, escape from the autophagic machinery via ex­
pression of the VirG protein, which is capable of inhibiting 
Atg5  function  in  nonphagocytic  cells  (Ogawa  et  al.,  2005).   
Immunity­related GTPase family M, an IFN­–inducible GTPase, 
promotes autophagy, and the autophagic machinery effectively 
eliminates mycobacteria in macrophages (Gutierrez et al., 2004;   
Singh et al., 2006). Sequestosome 1 (SQSTM1)/p62, which inter­
acts with both LC3 and ubiquitinated proteins, is recruited to   
bacteria­containing  ubiquitinated  vacuoles  upon  infection  and 
promotes the killing of invading pathogens by autophagy (Bjørkøy 
et al., 2005; Komatsu et al., 2007; Yoshikawa et al., 2009;   
Ponpuak et al., 2010). In addition to the formation of autophago­
somes, Atgs are responsible for the transport of Irga6, an   
immunity­related GTPase, from the ER–Golgi to the vacuoles 
containing invading microbes, which is a function required for 
the elimination of Toxoplasma gondii by macrophages (Zhao et al., 
2008). These findings clearly demonstrate that Atgs are critical 
for the direct elimination of infectious agents. Autophagy also 
plays an indispensable role in antigen presentation to antigen­
specific T cells (a process essential for the induction of acquired 
immunity; Gannagé and Münz, 2009). Major histocompatibility 
complex (MHC) class II molecules are localized on autophago­
somes, and the autophagic machinery promotes the presentation 
of viral and self­antigens by MHC class II molecules to antigen­
specific CD4
+ T cells (Nimmerjahn et al., 2003; Dengjel et al., 
2005; Paludan et al., 2005; Zhou et al., 2005; Schmid et al., 2007; 
Nedjic et al., 2008; Jagannath et al., 2009; Lee et al., 2010). Upon 
infection by human simplex virus 1, autophagy controls the MHC 
class I–dependent presentation of viral antigens to CD8
+ T cells 
(English et al., 2009).
In addition to these functions, recent studies reveal that 
Atgs are important for innate immune responses provoked by the 
engagement of PRRs with microbial components. In this review, 
we discuss this recent evidence and its relevance to inflamma­
tory disease.
Figure 1.  Atgs are essential components for 
autophagosome formation. Autophagy, a bulk 
degradation system, is induced after sensing 
various types of stress, such as nutrient starva-
tion, the accumulation of protein aggregates, 
and invasion by microbes. This system enables 
the reuse of cellular components and the clear-
ance of unfavorable substances, thus contribut-
ing to the maintenance of cellular homeostasis 
and  the  prevention  of  disease.  Atgs  are  re-
cruited  to  the  isolation  membrane,  a  source 
membrane  of  autophagosomes,  and  play  a 
vital role in driving the membrane trafficking 
necessary  for  the  generation  of  autophago-
somes. Autophagosomes then fuse with lyso-
somes to become autolysosomes, leading to 
the  degradation  of  the  constituents  trapped 
inside. PE, phosphatidylethanolamine.927 Regulation of innate immune responses by autophagy-related proteins • Saitoh and Akira
dextran sulfate sodium–induced colitis, which is relieved by the 
injection of anti–IL­1 and anti–IL­18 antibodies. These find­
ings indicate that the loss of Atg16L1, an essential component   
of the autophagic machinery, results in the production of inflam­
matory cytokines in response to endotoxin. However, the source 
of the ROS has not yet been identified. One candidate source is 
NADPH oxidase (Dostert et al., 2008). Other possible sources of 
ROS include mitochondria because autophagy is required for the 
clearance  of  old/damaged  mitochondria.  Recent  studies  have 
shown that loss of the Atg results in the accumulation of ROS in 
immune­competent cells, such as T cells, as a result of the dis­
ruption of mitochondrial turnover (Pua et al., 2009; Stephenson 
et al., 2009). Further studies are needed to elucidate the source of 
ROS in macrophages deficient in Atgs.
the regulation of the inflammatory response. Stimulation of the 
other TLR family members (except for TLR3) fails to induce 
this enhanced production of IL­1 by Atg16L1­deficient macro­
phages. TRIF (Toll/IL­1 receptor domain–containing adaptor in­
ducing IFN­), the adaptor protein involved in TLR3/4 signaling 
pathways, also mediates IL­1 production in Atg16L1­deficient 
macrophages. It was shown that ATP, uric acid crystals, silicas, 
and asbestos induce the generation of reactive oxygen species 
(ROS), leading to the activation of caspase­1, an essential prote­
ase for IL­1 production (Dostert et al., 2008; Stutz et al., 2009; 
Zhou et al., 2010). In Atg16L1­deficient macrophages, the en­
hanced IL­1 production is induced by TRIF­dependent genera­
tion of ROS and is blocked by ROS scavengers. Mice with 
hematopoietic cells lacking Atg16L1 are highly susceptible to 
Figure 2.  TLR response and Atgs. (A) Atgs con-
trol endotoxin-induced IL-1 production. TLR4 
triggers both MyD88- and TRIF-dependent sig-
naling pathways after sensing LPS. The IKK-– 
IKK-–NEMO complex mediates the activation 
of the transcription factor NF-B, which in turn 
induces  the  transcription  of  proinflammatory 
cytokines and pro–IL-1. The TBK1–IKK-i com-
plex mediates the activation of the transcription 
factor IRF3, which then induces the transcrip-
tion of type I IFNs and IFN-inducible genes. In   
autophagy-deficient cells, high levels of ROS 
are generated, which mediate TRIF-dependent 
caspase-1 activation, resulting in the process-
ing  of  IL-1.  However,  in  wild-type  macro-
phages, limited amounts of IL-1 are induced 
by LPS as the result of a lack of ROS generation.   
(B) Atgs contribute to TLR-dependent elimina-
tion of pathogens. After detection of the fungal 
cell  wall  component  zymosan,  TLR2  induces 
the maturation of phagosomes, leading to the 
elimination of the fungus. Atgs such as Atg5, 
Atg7, and PI3K are involved in the fusion of 
phagosomes with lysosomes. (C) Ligands for 
TLR7 such as ssRNA and imiquimod induce the 
formation of autophagosomes via MyD88, an 
essential adaptor molecule, and promote the 
elimination of Bacillus Calmette-Guerin. LPS, a 
ligand for TLR4, induces the formation of auto-
phagosomes via the TRIF-p38 signaling axis, 
leading  to  the  elimination  of  Mycobacterial   
bacilli. Atgs such as Atg5, beclin, and PI3K 
are required for the formation of autophago-
somes by TLR stimulation.JCB • VOLUME 189 • NUMBER 6 • 2010   928
of autophagosomes in primary human monocytes, although it 
fails to induce autophagy in primary mouse macrophages (Xu   
et al., 2007; Saitoh et al., 2008). The signal transducers, TRIF, 
RIPK1 (receptor­interacting protein kinase 1), and p38, are re­
quired  for  the  TLR4­induced  formation  of  GFP­LC3  dots  in   
macrophage cell lines. Further studies are required to explain the 
cell type– or species­specific induction of autophagy by LPS and 
to identify the target of p38, whose phosphorylation is responsi­
ble for the activation of Atgs.
Autophagy and antibacterial responses
Nod1 (nucleotide­binding oligomerization domain 1) and Nod2 
are intracellular sensors that recognize the unique bacterial poly­
peptides iE­DAP (­d­glutamyl­meso­diaminopimelic acid) and 
muramyl dipeptide (MDP), respectively (Franchi et al., 2009). 
Thus, Nod1 and Nod2 detect invading bacteria and play a central 
role in the production of cytokines and antimicrobial peptides. 
Importantly, a strong relationship has been found between Nod2 
mutation and the development of Crohn’s disease (Cho and 
Weaver, 2007). It has also been shown that Nod1 is a candidate 
gene responsible for susceptibility to Crohn’s disease (McGovern 
et al., 2005). Indeed, immune responses to bacterial polypeptides 
and  microbial  infection  are  impaired  in  cells  isolated  from   
patients  harboring  Nod2  mutations  (Franchi  et  al.,  2009).  In 
mouse models, Nod1 or Nod2 deficiency results in enhanced   
intestinal inflammation upon bacterial infection as a result of   
the disruption of innate immune responses. Furthermore, Nod2 
mutant mice, whose Nod2 locus harbors the homologue of the 
most common Crohn’s disease susceptibility allele 3020insC, 
are highly sensitive to chemical­induced colitis because of the 
enhanced  production  of  proinflammatory  cytokines  such  as   
IL­1 and IL­1 (Maeda et al., 2005). Because a single nucleo­
tide polymorphism in the Atg16L1 gene is also associated with 
the development of Crohn’s disease (Hampe et al., 2007; Rioux 
et al., 2007), the involvement of Nod1 and Nod2 in the induction 
of autophagy was assessed. Cooney et al. (2010) found that stim­
ulation of Nod2 by MDP induces the formation of autophago­
somes, thus promoting antigen presentation on MHC class II 
molecules by human DCs (Fig. 3). Atgs such as Atg5, Atg7, and 
Atg16L1 are required for the induction of autophagy in human 
DCs and the subsequent promotion of antigen presentation by 
MDP (Cooney et al., 2010). RIPK2, one of the downstream   
regulators of the Nod2 signaling pathway, is also involved in 
MDP­induced formation of autophagosomes. Importantly, DCs 
expressing Crohn’s disease–associated Nod2 or ATG16L1 vari­
ants fail to induce autophagosome formation and antigen presen­
tation in response to MDP. Travassos et al. (2010) also found that 
stimulation with both Nod1 and Nod2 triggers the induction   
of autophagy in mouse embryonic fibroblasts (MEFs), mouse 
macrophages, human lymphoblasts, and human cell lines (Fig. 3). 
However, Nod1 and Nod2 are not necessary for the formation of 
autophagosomes induced by nutrient starvation and rapamycin 
treatment, indicating that Nod1 and Nod2 are specifically in­
volved in the formation of bacteria autophagosomes. In MEFs, 
Nod1, but not the downstream signaling molecules RIPK2 and 
IB kinase­/NEMO, is required for the generation of S. flexneri–
containing autophagosomes and promotes the elimination of 
Autophagy and TLR signaling
Recent studies have demonstrated that TLR signaling induces   
the maturation of phagosomes after exposure to bacteria and pro­
motes MHC class II–dependent presentation of bacterial antigens 
(Blander and Medzhitov, 2004, 2006). Sanjuan et al. (2007) as­
sessed the involvement of Atgs in the maturation of phagosomes 
after exposure to microbial components and found that zymosan 
particles (cell wall components of fungi) stimulate TLR2, thus 
promoting  the  fusion  of  GFP­LC3–positive  phagosomes  with   
lysosomes  in  macrophages  (Fig.  2  B).  Surprisingly,  MyD88   
(myeloid differentiation primary response gene 88), an essential 
adaptor molecule for cytokine production via TLR2 stimulation, 
is not necessary for the recruitment of GFP­LC3 to phagosomes 
by zymosan, suggesting that TLR2 triggers an as yet–unidentified 
pathway to induce the maturation of phagosomes. Atgs such as 
Atg5, Atg7, and PI3K are required for the efficient maturation of 
phagosomes induced by TLR2. Consistently, macrophages lack­
ing Atg7 fail to eliminate live yeasts in phagolysosomes. Sanjuan 
et al. (2007) also mentioned that Pam3CSK4, a soluble TLR2   
ligand, fails to increase the number of GFP­LC3–positive phago­
somes, but Pam3CSK4 fused with latex beads induces the 
maturation of phagosomes in primary macrophages. Thus, TLR2 
signaling is necessary but not sufficient for the induction of 
phagosome maturation. Although Atgs are important for the   
maturation  of  phagosomes  after TLR2  stimulation,  subsequent   
characterization by electron microscopy shows that the GFP­LC3–
positive phagosomes do not have the morphological characteris­
tics of autophagosomes, indicating that TLR2 stimulation induces 
the Atg­dependent, but autophagy­independent, exclusion of fungi 
in phagolysosomes. It would be of interest to examine how zymo­
san activates the function of Atgs via a TLR2­dependent but 
MyD88­independent pathway and how Atgs promote the fusion 
of phagosomes with lysosomes in macrophages. Because the 
receptor dectin­1, which recognizes the ­glucan structure in 
zymosan, can activate the tyrosine protein kinase Syk­dependent 
signaling pathway and promote uptake of zymosan (Brown and 
Gordon, 2001; Brown et al., 2003; Gantner et al., 2003; Rogers 
et al., 2005), it will be important to assess the involvement of this 
receptor in the Atg­dependent maturation of phagosomes after 
infection by fungal pathogens.
The  TLR­dependent  induction  of  autophagy  in  macro­
phages/monocytes has been reported by other groups. Delgado   
et al. (2008) reported that the engagement of TLR7 induces   
autophagy and promotes the elimination of Bacillus Calmette-
Guerin in autolysosomes (Fig. 2 C). Both Atg5 and beclin are 
required for the induction of autophagy in macrophages after 
TLR7 stimulation. Although MyD88 is not necessary for the for­
mation of GFP­LC3 dots after stimulation by zymosan, it is in­
volved in the formation of GFP­LC3 dots after stimulation of 
TLR7 (Sanjuan et al., 2007; Delgado et al., 2008). It would be of 
interest to examine the reasons why MyD88 is differentially in­
volved in the formation of GFP­LC3 dots after the engagement of 
TLRs and how MyD88 signals Atgs to induce the formation of 
autophagosomes. However, Xu et al. (2007) reported that TLR4 
stimulation results in the PI3K­dependent formation of GFP­LC3 
dots and enhances the elimination of mycobacteria in macro­
phage cell lines (Fig. 2 C). LPS stimulation increases the number 929 Regulation of innate immune responses by autophagy-related proteins • Saitoh and Akira
a CARD­containing mitochondrial protein, activates the tran­
scription factors IRF3 and NF­B via the IB kinase family, 
leading to the production of type I IFN and the expression of 
IFN­inducible genes. Recent studies have shown an important 
role for Atgs in both TLR­dependent and RLR­dependent anti­
viral innate immune responses (Jounai et al., 2007; Lee et al., 
2007; Tal et al., 2009).
Two models have been proposed for the involvement of 
Atgs in RLR­mediated innate immune responses. Jounai et al. 
(2007) found a possible role for Atg12­Atg5 conjugates in the 
disruption of the RLR–IPS­1 signaling pathway (Fig. 4 A). The 
Atg12­Atg5 conjugate associates with the CARD domains of 
RLR and IPS­1, and ectopic expression of Atg12 or Atg5 pre­
vents RLR­ or IPS­1–mediated activation of the type I IFN pro­
moter. Consistently, loss of Atg5 enhances the production of type I 
IFN by vesicular stomatitis virus (VSV) infection and dsRNA 
treatment and limits the replication of VSV in MEFs. Loss of 
Atg7, an essential requirement for the conjugation of Atg12 with 
Atg5, also results in enhanced type I IFN production by dsRNA 
(Jounai et al., 2007). However, Tal et al. (2009) showed that the 
disruption of cellular homeostasis by a deficiency in autophagy 
affects RLR–IPS­1 signaling pathways (Fig. 4 A). In cells lacking 
Atg5, old/damaged mitochondria accumulate because of the loss 
of autophagy, resulting in the elevated expression of the IPS­1 
protein. RLR stimulation triggers an elevation in ROS production 
by the accumulated mitochondria, leading to the activation of 
IPS­1–dependent innate immune responses in Atg5­deficient cells. 
Further analysis will be required to reveal the mechanisms re­
sponsible for the ROS­dependent activation of RLR signaling.
Lee et al. (2007) reported that autophagy is necessary for 
the TLR7­dependent production of type I IFNs and cytokines in 
pDCs after RNA virus infection (Fig. 4 B). Loss of Atg5, or phar­
macological inhibition of PI3K, severely impairs the production 
of both type I IFN and cytokine IL­12 p40 by pDC infected with 
VSV and Sendai virus. The number of autophagosomes in pDCs 
does not increase after TLR7 stimulation, indicating that basal 
autophagy, which constitutively occurs under nutrient­rich con­
ditions, is responsible for the TLR7­dependent induction of 
innate immune responses in pDCs. These findings suggested that 
the viral ssRNA from replicating VSV or Sendai virus is gener­
ated in autophagosomes, or autolysosomes, in pDCs, resulting in 
the TLR7­dependent production of type I IFNs and proinflamma­
tory cytokines. Lee et al. (2007) also reported that the production 
of type I IFN but not IL­12 p40 by A/D­type unmethylated CpG 
oligonucleotides  (a  ligand  for TLR9)  is  severely  impaired  in 
Atg5­deficient pDCs. Because TLR7 and TLR9 share the signal­
ing pathway that induces type I IFN, autophagy or Atgs might be 
involved in signaling events required for TLR7/TLR9­dependent 
type I IFN production in pDCs.
B cell activation by  
DNA-containing antigens in 
autophagosome-like compartments
It  is  known  that  hyperactivation  of  B  cells  by  nucleic  acid– 
containing antigens results in the development of autoimmune 
diseases  such  as  systemic  lupus  erythematosus  (Marshak­ 
Rothstein, 2006). Although B cell receptors (BCRs) on the cell 
the invading bacteria. Interestingly, both Nod1 and Nod2   
associate with Atg16L1 and recruit it to the bacterial entry sites 
after bacterial infection. The most common Nod2 mutation as­
sociated with Crohn’s disease fails to induce the movement of 
Atg16L1 and the formation of autophagosomes. These studies 
indicate a role for both Nod1 and Nod2 in the formation of bac­
teria autophagosomes and in the regulation of antimicrobial re­
sponses. However, the signaling pathways downstream of Nod1 
and Nod2 that are responsible for the induction of bacteria auto­
phagosomes remain unclear. Further studies are still needed to 
clarify this issue.
Atgs and antiviral IFN responses
For host defense against RNA viruses, type I IFNs (IFN­ and 
IFN­) induce the expression of a series of antiviral factors   
and play crucial roles in the establishment of an antiviral state 
(Beutler,  2009;  Kawai  and Akira,  2009).  Plasmacytoid  DCs 
(pDCs) detect the single­stranded RNA (ssRNA) of RNA vi­
ruses via TLR7, which is expressed on endolysosomes. TLR7 
stimulates IRF7 (IFN regulatory factor 7), a transcription factor 
that induces IFN stimulation­responsive element­dependent 
transcription via the adaptor molecule MyD88 and mediates the 
production of type I IFNs by pDCs. In cell types retinoic acid–
inducible  gene  I  (RIG­I)  and  MDA­5,  caspase  recruitment   
domain  (CARD)–containing  RNA  helicases  called  RIG­like   
receptors (RLRs) sense the cytoplasmic double­stranded RNA 
(dsRNA) of RNA viruses and mediate signals to IPS­1 (IFN­ 
promoter stimulator­1; also called MAVS/VISA/Cardif). IPS­1, 
Figure 3.  Sensing of bacterial polypeptides by Nod1 and Nod2 triggers 
the formation of autophagosomes. Nod1 and Nod2 are composed of 
N-terminal CARDs, a centrally located nucleotide-binding oligomeriza-
tion domain (NOD), and multiple C-terminal leucine-rich repeats (LRRs). 
The leucine-rich repeats of Nod1 and Nod2 detect iE-DAP and MDP, 
respectively. After sensing these ligands, Nod1 and Nod2 induce the 
formation of autophagosomes, leading to the promotion of antigen pre-
sentation and the enhancement of bactericidal responses. Atgs such as 
Atg5, Atg7, and Atg16L1 are involved in Nod1- and Nod2-mediated 
formation of autophagosomes.JCB • VOLUME 189 • NUMBER 6 • 2010   930
depolymerization, inhibits the translocation of TLR9 and the sub­
sequent hyperactivation of MAPK by DNA­containing antigens. 
Thus, the movement of BCR and TLR9 induced by DNA­ 
containing antigens and the colocalization of the receptors and   
DNA­containing antigens in autophagosome­like compartments 
facilitates the efficient engagement of the receptors, resulting in 
the synergistic activation of downstream signaling cascades. 
Study of primary B cells lacking Atgs is needed to elucidate   
the requirement for autophagosomes in the BCR­ and TLR­ 
dependent activation of B cells by DNA­containing antigens.
Atg9a and double-stranded DNA (dsDNA)–
induced innate immune responses
Microbial DNA induces the expression of type I IFNs and pro­
inflammatory cytokines, leading to the potent induction of innate 
surface and TLR7/TLR9 in the endolysosomes are involved in 
hyperimmune responses to nucleic acid–containing antigens, it is 
unclear how nucleic acid–containing antigens induce the aberrant 
activation of B cells via these receptors. Chaturvedi et al. (2008) 
found that stimulation of BCR by DNA­containing antigens results 
in the translocation of both the BCR and TLR9 to autophagosome­
like compartments where the DNA­containing antigens are   
accumulated (Fig. 5). Inhibition of PLD, but not diacylglycerol   
kinase, blocks the translocation of TLR9 after it engages the BCR, 
suggesting that BCR stimulation induces the PLD­dependent gen­
eration of phosphatidic acid to promote the recruitment of TLR9 
to autophagosome­like compartments. The movement of TLR9 
from the endosome into the autophagosome­like compartments 
on BCR stimulation depends on a functional microtubular 
network. Treatment with nocodazole, an inducer of tubulin   
Figure 4.  Regulation of nucleic acid–induced 
type I IFN production by Atgs. (A) RIG-I and 
MDA-5,  CARD-containing  RNA  helicases, 
sense viral dsRNA and signal to IPS-1, a CARD-
containing  adaptor  molecule,  to  induce  the 
expression of type I IFN/IFN-inducible genes 
and  proinflammatory  cytokines.  Atg12-Atg5 
conjugates are recruited to the CARD domains 
of RIG-I, MDA-5, and IPS-1 and suppress the 
dsRNA-induced  innate  immune  response. 
(B) TLR7 detects viral ssRNA and induces in-
nate  immune  responses.  Targeted  disruption 
of Atg5 or pharmacological inhibition of PI3K 
results  in  the  impairment  of  TLR7-mediated 
expression of type I IFN/IFN-inducible genes 
and proinflammatory cytokines. (C) STING, a 
multispanning membrane protein, and TBK1, 
an IRF3 kinase, mediate the induction of innate 
immune  responses  by  dsDNA.  After  sensing 
dsDNA, STING moves from the ER to the Golgi 
apparatus and finally reaches the cytoplasmic 
punctate  structures  to  assemble  with  TBK1, 
resulting in the IRF3-dependent expression of 
type  I  IFNs/IFN-inducible  genes.  STING  co-
localizes with Atg9a in the Golgi apparatus 
after  dsDNA  stimulation.  The  loss  of  Atg9a 
greatly enhances the dsDNA-induced assem-
bly of STING and TBK1, leading to aberrant 
activation of the innate immune response.931 Regulation of innate immune responses by autophagy-related proteins • Saitoh and Akira
the transcription factor IRF3, leading to the activation of IFN­
stimulated response element–dependent transcription of type I 
IFN/IFN­inducible genes. STING is a multispanning membrane 
protein that associates with TBK1 to mediate dsDNA­induced 
signaling pathways. Regulators acting upstream of STING 
have not yet been identified. Recently, we and other groups 
reported that the translocation and assembly of these essential 
signal transducers (STING and TBK1) are required for dsDNA­
triggered innate immune responses (Fig. 4 C; Ishikawa et al., 
2009; Saitoh et al., 2009). After stimulation with dsDNA, STING 
moves from the ER to the Golgi apparatus, finally reaching the 
cytoplasmic punctate structures to assemble with TBK1. EXOC2/
Sec5, a component of the exocyst complex responsible for tar­
geting exocytic vesicles to specific docking sites on the plasma 
membrane, colocalizes with STING and regulates innate immune 
responses to dsDNA. Thus, it is clear that a membrane trafficking 
system mediates the dynamic movement of STING, leading to 
the efficient induction of innate immune responses to dsDNA. We 
assessed involvement of Atgs in the translocation of STING and 
found that, after dsDNA stimulation, STING colocalizes with 
Atg9a in the Golgi apparatus and with LC3 in cytoplasmic punc­
tate structures but not with other Atgs (Fig. 4 C; Saitoh et al., 
2009). Characterization by electron microscopy revealed that the 
STING­positive puncta induced by dsDNA stimulation did not 
have the morphological characteristics of autophagosomes but 
were  unidentified  membrane­bound  compartments,  suggesting   
a unique function of Atg9a or LC3 in the regulation of innate   
immune responses. Atg9a is the only multispanning membrane 
protein  identified  as  an Atg  in  mammals  and  localizes  to   
the Golgi apparatus and late endosomes (Yamada et al., 2005; 
Webber and Tooze, 2010). Atg9a does not reside at one site, but 
rather, it dynamically cycles between these organelles under star­
vation conditions, mediating membrane transport to generate   
autophagosomes. Mice lacking Atg9a cannot survive neonatal 
starvation periods, and cells lacking Atg9a are deficient in the gen­
eration of autophagosomes under both nutrient­rich and nutrient­
starved conditions, indicating that Atg9a is an essential component 
of autophagy (Saitoh et al., 2009). Interestingly, the loss of Atg9a 
greatly enhances the assembly of STING and TBK1 triggered by 
dsDNA, leading to aberrant activation of the innate immune re­
sponse (Fig. 4 C). However, both the localization of STING and 
cytokine  production  are  almost  normal  in  dsDNA­stimulated 
MEFs lacking either Atg7 or Atg16L1. Thus, deficiency of 
Atg9a, but not of autophagy, affects the movement of STING   
and TBK1 after dsDNA stimulation. Further studies are needed to   
reveal the unique function of Atg9a involved in the regulation of 
the membrane trafficking responsible for the assembly of STING 
and to assess importance of Atg9a in host defense against DNA 
viruses and pathogenic bacteria.
Conclusion
Recent advances in the study of the involvement of Atgs in   
innate immunity have clearly demonstrated the importance of 
membrane  trafficking  systems  to  host  defense.  However,  in 
some cases, it is still unclear whether autophagy or Atgs are   
involved  in  the  control  of  PRR­mediated  innate  immune   
responses. Furthermore, it is difficult to judge whether the 
immunity (Stetson and Medzhitov, 2006a; Kawai and Akira, 2009). 
Furthermore,  synthesized  DNA  stimulates  the  innate  immune 
system and acts as a good adjuvant to induce the efficient induc­
tion of acquired immune responses (Ishii et al., 2008a). Indeed, 
TLR9,  the  receptor  for  single­stranded  DNAs  containing  un­
methylated CpG motifs, is involved in the protection of hosts suf­
fering DNA virus infection, and the ligands for TLR9 efficiently 
induce acquired immune responses upon vaccination. However, 
dsDNA derived from bacteria and DNA viruses, as well as host 
genomic DNA from dying cells, could induce the expression of 
both type I IFNs and IFN­inducible genes via a TLR­independent 
pathway  (Okabe  et  al.,  2005;  Ishii  et  al.,  2006;  Stetson  and   
Medzhitov, 2006b; Stetson et al., 2008). Although the specific sen­
sors involved in dsDNA­induced innate immune responses are 
still unclear, recent studies have revealed that TBK1 (TANK­
binding kinase 1) and stimulator of IFN genes (STING; also called 
MPYS/MITA/ERIS), function as mediators in dsDNA­induced 
production of type I IFN (Ishii et al., 2006; Stetson and Medzhitov, 
2006b; Ishikawa and Barber, 2008; Jin et al., 2008; Zhong et al., 
2008; Sun et al., 2009). Both TBK1 and STING are also required 
for the efficient induction of acquired immune responses by 
DNA­based vaccines and play a key role in host defense against 
the DNA virus herpes simplex virus 1 (Ishii et al., 2008b; Ishikawa 
et al., 2009). Upon stimulation by dsDNA, TBK1 phosphorylates 
Figure 5.  DNA-containing antigens induce TLR9 signal from autophagosome- 
like compartments. DNA-containing antigens stimulate BCRs, leading 
to the translocation of TLR9 from the endosomes to autophagosome-like 
compartments. DNA-containing antigens also promote the movement of 
BCRs from the cell surface to autophagosome-like compartments. In these 
autophagosome-like compartments, DNA-containing antigens trigger both 
BCR and TLR9 signaling pathways, resulting in the synergistic activation of 
MAPK. Functional PLD and microtubules are required for the translocation 
of these receptors and play a critical role in the hyperresponse to DNA-
containing antigens.JCB • VOLUME 189 • NUMBER 6 • 2010   932
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